Facebook
Twitter
LinkedIn
ForwardCMHC Masterclass CME Information
ACTIVITY TITLE
CMHC Masterclass
Frontiers in Interventional Cardiology: Advances & Expert Perspectives
ACTIVITY DATE
January 28-29, 2022 | Live Online | Eastern Time
EDUCATIONAL SUPPORT
This activity is supported in part by an educational grant from Medtronic.
TARGET AUDIENCE
US-based healthcare professionals, including primary care clinicians (PCPs), interventional cardiologists, cardiologists, registered nurses, advanced practice registered nurses, dieticians, pharmacists, and other allied health professionals.
PROGRAM OVERVIEW
This masterclass is designed to explore the latest advances about the most pertinent domains in interventional cardiology. Multidisciplinary experts will present on comprehensive interventional cardiology topics, including pre-procedural evaluation, pharmacological aspects, coronary intervention, peripheral intervention, structural intervention, and more. Each section will include patient cases and expert panel discussion, which will aim to provide practical approaches to patient management and interpret the latest advances to patient care.
EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:
- Integrate advances in the screening, diagnosis, and risk assessment for patients with stable coronary and peripheral artery disease, as well those with acute coronary syndrome
- Outline appropriate pharmacotherapy for patients ACS, CAD, and PAD before and after procedural interventions
- Interpret the results from key clinical trials and evidence for patients with structural and valvular heart disease
- Evaluate the role of pharmacotherapy and evidence-based interventional technologies for the management of atrial fibrillation and arrhythmias
- Discuss advances in pharmacotherapy and endovascular thrombectomy for stroke prevention inpatients with arrhythmias or VTE
- Develop individualized treatment options and interventions for patients with CAD, PAD, ACS, arrhythmias, VTE, and structural/valvular heart disease that incorporate the latest advances in interventional technologies, drugs, and procedures to optimize outcomes
FACULTY
Please click here to view all faculty listings.
PROGRAM AGENDA
Please click here to view the full agenda.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CMHC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CONTINUING MEDICAL EDUCATION
The Postgraduate Institute for Medicine designates this live activity for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CONTINUING PHARMACY EDUCATION
Postgraduate Institute for Medicine designates this continuing education activity for 10 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education.
This is a knowledge-based activity. Universal Activity Numbers (UAN) JA4008162-9999-22-035-L01-P.
For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor within 4-6 weeks. Pharmacists have up to thirty (30) days from the live event to complete the evaluation and claim credit.
CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 10 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.
CONTINUING DIETICIAN EDUCATION
This program offers 10 CPEUs for dieticians.
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The PIM planners and others have nothing to disclose. The CMHC planners and others have nothing to disclose.
Faculty
A full listing of faculty disclosures will be provided here.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
REQUEST FOR CREDIT
This information is coming soon.
FEE INFORMATION & REFUND/CANCELLATION POLICY
There is no registration fee for participating and receiving CME/CE credit for this educational activity.